Monoclonal anti-IgE antibodies in the diagnosis of dog allergy

被引:0
|
作者
Derer, M [1 ]
Morrison-Smith, G [1 ]
De Weck, AL [1 ]
机构
[1] CMG Labs Fribourg, CH-1700 Fribourg, Switzerland
关键词
dog IgE; monoclonal antibody;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The availability of anti-dog IgE monoclonal antibodies has enabled development of highly specific ELISA assays for measuring antigen-specific IgE in dog serum. In this article the authors propose criteria for evaluation of these monoclonals and demonstrate that some anti-human IgE monoclonals recognize dog IgE. Combinations of two or more monoclonal antibodies can enhance assay sensitivity; for example, a mixture of DE38.HRPO and 4F4.HRPO conjugates detect total dog IgE in the range 10-10000 ng/mL. Results are reported from nine clinical studies conducted in Europe, Japan and Australia involving more than 400 dogs in which serologic IgE determinations performed using the CMG IMMUNODOT strip system for house dust mites, storage mites, flea, grass pollens and moulds were compared with immediate skin test findings. House dust mites were identified as the common major dog allergen throughout these areas although regional reactions to food allergens were observed. These results confirm that the CMG IMMUNODOT system is a valuable and reliable diagnostic test for dog allergy.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 50 条
  • [1] Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy
    Guilleminault, Laurent
    Michelet, Marine
    Reber, Laurent Lionel
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 62 (01) : 216 - 231
  • [2] Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy
    Laurent Guilleminault
    Marine Michelet
    Laurent Lionel Reber
    [J]. Clinical Reviews in Allergy & Immunology, 2022, 62 : 216 - 231
  • [3] Anti-IgE monoclonal antibody as a treatment of severe food allergy
    Pena-Peloche, M.
    Hinojosa-Macias, M.
    de la Hoz-Caballer, B.
    Terrados-Cepeda, S.
    Farrarons-Llorente, L.
    Alvarez-Cuesta, E.
    [J]. ALLERGY, 2011, 66 : 65 - 65
  • [4] Anti-IgE and SIT in respiratory allergy
    Lau, S.
    [J]. ALLERGOLOGIE, 2012, 35 (10) : 530 - 530
  • [5] Omalizumab: Anti-IgE Therapy in Allergy
    Matthias Volkmar Kopp
    [J]. Current Allergy and Asthma Reports, 2011, 11 : 101 - 106
  • [6] Omalizumab: Anti-IgE Therapy in Allergy
    Kopp, Matthias Volkmar
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2011, 11 (02) : 101 - 106
  • [7] Anti-IgE monoclonal antibodies as potential treatment in COVID-19
    Farmani, Ahmad Reza
    Mahdavinezhad, Forough
    Moslemi, Rohollah
    Mehrabi, Zeinab
    Noori, Alireza
    Kouhestani, Mahsa
    Noroozi, Zahra
    Ai, Jafar
    Rezaei, Nima
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2021, 43 (03) : 259 - 264
  • [8] DOT-IMMUNOBINDING ASSAY WITH MONOCLONAL ANTI-IGE ANTIBODIES FOR THE DETECTION AND QUANTITATION OF HUMAN IGE
    HONG, CS
    STADLER, BM
    WALTI, M
    DEWECK, AI
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (02) : 195 - 202
  • [9] ANTI-IGE MONOCLONAL-ANTIBODIES AS TOOLS FOR DEMONSTRATION OF CUTANEOUS IGE BEARING DENDRITIC CELLS
    BIEBER, T
    RING, J
    RIEBER, EP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (03) : 284 - 284
  • [10] Therapeutic potential of anti-IgE antibodies
    Heusser, C
    Jardieu, P
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (06) : 805 - 813